Karyopharm Therapeutics Inc.
NASDAQ:KPTI
0.7365 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -143.099 | -165.291 | -124.088 | -196.273 | -199.59 | -178.407 | -128.984 | -109.577 | -118.181 | -75.777 | -33.947 | -15.888 | -10.311 |
| Depreciation & Amortization
| 0.53 | 0.621 | 0.789 | 0.972 | 0.974 | 0.735 | 0.713 | 0.717 | 0.634 | 0.323 | 0.144 | 0.122 | 0.083 |
| Deferred Income Tax
| -1.114 | 0 | 1.454 | 0.904 | -1.382 | 0.029 | 0 | 0 | 1.778 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 21.709 | 35.399 | 29.783 | 24.407 | 15.291 | 17.275 | 20.405 | 22.283 | 17.057 | 14.24 | 3.785 | 0.653 | 0.024 |
| Change In Working Capital
| 31.415 | -19.989 | -23.189 | 1.356 | -13.308 | -0.169 | 32.962 | 0.987 | 3.998 | 9.715 | -0.36 | -0.396 | 1.655 |
| Accounts Receivables
| 20.124 | -5.084 | -9.616 | -5.019 | -7.862 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 1.181 | -0.118 | -1.462 | -2.627 | -0.346 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.35 | 1.17 | -2.847 | 3.465 | -3.301 | -1.38 | 0.909 | 0.945 | -2.426 | 4.496 | 0.664 | -0.066 | 1.131 |
| Other Working Capital
| 9.76 | -15.957 | -9.264 | 5.537 | -1.799 | 1.211 | 32.053 | 0.042 | 6.424 | 5.219 | -1.024 | -0.33 | 0.524 |
| Other Non Cash Items
| -2.164 | -0.294 | 8.135 | 8.4 | 7.193 | 1.42 | 1.187 | 1.199 | 0.685 | 0.052 | 0.088 | 0.257 | 0 |
| Operating Cash Flow
| -92.723 | -149.554 | -107.116 | -160.234 | -190.822 | -159.117 | -73.717 | -84.391 | -94.029 | -51.447 | -30.29 | -15.509 | -8.549 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| 0 | -0.118 | -5.712 | -0.145 | -0.206 | -2.363 | -0.062 | -0.07 | -1.416 | -2.834 | -0.057 | -0.121 | -0.376 |
| Acquisitions Net
| 0 | 104.256 | 5.5 | 53.54 | -78.656 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -159.151 | -226.016 | -45.228 | -274.577 | -178.489 | -242.811 | -98.374 | -134.7 | -305.192 | -63.797 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 167.091 | 121.878 | 192.78 | 221.037 | 257.145 | 137.51 | 115.544 | 159.365 | 215.867 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 7.94 | -104.256 | -5.5 | -53.54 | 78.656 | -105.301 | 17.17 | 24.665 | -0.082 | -0.4 | 0 | 0 | 0 |
| Investing Cash Flow
| 7.94 | -104.256 | 141.84 | -53.685 | 78.45 | -107.664 | 17.108 | 24.595 | -90.823 | -67.031 | -0.057 | -0.121 | -0.376 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 0 | -60 | 0 | 0 | -166.885 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 1.124 | 193.738 | 9.903 | 161.776 | 46.191 | 145.705 | 74.885 | 50.573 | 92.7 | 112.837 | 113.155 | 0.009 | 0.012 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.039 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 1.124 | 193.738 | 123.745 | 10.307 | 78.114 | 170.404 | 0.858 | 0.591 | 92.7 | 0.284 | 72.775 | 9.5 | 11.98 |
| Financing Cash Flow
| 1.124 | 193.738 | 73.648 | 172.083 | 124.305 | 316.109 | 75.743 | 51.164 | 92.7 | 113.121 | 185.93 | 9.509 | 11.992 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| -0.034 | -0.488 | -0.048 | 0.268 | 0.019 | -0.078 | 0.2 | -0.063 | -0.099 | -0.008 | 0 | 0 | 0 |
| Net Change In Cash
| -83.361 | -60.56 | 108.324 | -41.568 | 11.952 | 49.25 | 19.334 | -8.695 | -92.251 | -5.365 | 155.583 | -6.121 | 3.067 |
| Cash At End Of Period
| 52.891 | 136.885 | 197.445 | 89.121 | 130.689 | 118.737 | 68.997 | 49.663 | 58.358 | 150.609 | 155.974 | 0.391 | 6.512 |